Connect Biopharma Holdings Ltd SEC filings CNTB
Connect Biopharma Holdings Ltd has 196 filings in SEC EDGAR's recent list, going back to Dec 17, 2020. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 30, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| F-3 | Shelf registration (foreign issuer) | May 15, 2026 | — |
| POS AM | Filing | Sep 10, 2025 | — |
| F-6 POS | Filing | Jul 18, 2025 | — |
| S-8 | Employee stock plan registration | Jun 10, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Jun 10, 2025 | — |
| S-8 | Employee stock plan registration | Jul 1, 2022 | — |
| F-3/A | Filing | Jun 17, 2022 | — |
| F-3/A | Filing | May 23, 2022 | — |
| F-3 | Shelf registration (foreign issuer) | Apr 15, 2022 | — |
| S-8 | Employee stock plan registration | Mar 19, 2021 | — |
| 424B4 | Prospectus | Mar 19, 2021 | — |
| F-1MEF | Filing | Mar 18, 2021 | — |
| F-1/A | Filing | Mar 18, 2021 | — |
| F-1/A | Filing | Mar 17, 2021 | — |
| F-1/A | Filing | Mar 12, 2021 | — |
| F-6 | Filing | Mar 12, 2021 | — |
| F-1 | Registration statement (foreign issuer) | Feb 26, 2021 | — |
Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CNTB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- San Diego, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1835268
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.